Fatih Öztürk

Fatih Öztürk

Auto-generated profile, based on publicly available information

Fatih Öztürk

Department of Cardiology, Faculty of Medicine, Yuzunci Yil University, Van, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2020 in Angiology
Verified
Journal Article
Closed access
PDF file
FOFatih Ozturk
Fatih Ozturk
AAAdem Atici
Adem Atici
HBhasan ali barman
hasan ali barman
The main goals in the treatment of acute coronary syndrome are to prevent myocardial ischemia, damage, and possible complications. Accordingly, we evaluated the predictive value of glypican-6 (GPC6) for cardiac remodeling after myocardial infarction (MI). Baseline plasma GPC6 levels were measured in patients who underwent primary percutaneous coronary intervention (PCI) for acute MI. Left ventricular ejection fraction (LVEF) was measured at baseline and at 6 months with transthoracic echocardiography. Reduced LVEF persisted in 89 out of 276 patients after 6 months. The majority of the patients were male (n = 198, 72%) and the mean age was 57.8 ± 10.8 years. Glypican-6, N-terminal pro-brain natriuretic peptide (NT-proBNP), and high-sensitive troponin levels were significantly lower in the improved LVEF group compared with the low LVEF group (10.54 ± 4.46 vs 6.98 ± 3.34 ng/mL, P < .001; 500 pg/mL [range, 300-600 pg/mL] vs 350 pg/mL [range, 200-550 pg/mL], P = .008; 396 pg/mL [range, 159-579 pg/mL] vs 300 pg/mL [range, 100-500 pg/mL], P = .016, respectively). Logistic regression analysis revealed the SYNTAX Score 2, GPC6, and NT-proBNP as significant independent predictors of low LVEF (hazard ratio [HR]: 1.064, P = .041; HR: 1.215, P < .001; HR: 1.179, P < .001). Glypican-6 may prove to be useful for the detection of low LVEF development in patients undergoing PCI following MI.

1 February 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
FÖFatih Öztürk
Fatih Öztürk
NBNaci Babat
Naci Babat
CGCemil Göya
Cemil Göya
STSAİM TÜRKOĞLU
SAİM TÜRKOĞLU
MKmedeni karaduman
medeni karaduman
MTMustafa Tuncer
Mustafa Tuncer
OBJECTIVE: COVID-19 can cause lung damage and may present with pneumonia in patients. In the present study, the correlation between the severity of pneumonia and electrocardiography parameters of COVID-19 were examined. METHODS: A total of 93 COVID-19 patients and a control group consisting of 62 volunteers were studied. Computed thorax tomography evaluation was performed; each lung was divided into three zones. For each affected zone, scores were given. The main computed thorax tomography patterns were described in line with the terms defined by the Fleischner Society and peer reviewed literature on viral pneumonia. We compared Computed thorax tomography of patients with corrected QT (QTc) and P wave dispersion (Pd) time. RESULTS: There is a significant difference between the patient and control groups in terms of QTc values (413.5 +/- 28.8 msec vs. 395.6 +/- 16.7 msec p<0.001). Likewise, the Pd value of the patient group is statistically significantly higher than that of the control group (50.0 +/- 9.6 ms computed thorax tomography ec vs. 41.3 +/- 5.8 msec p<0.001). In the patient group, a reverse correlation was detected between computed thorax tomography score and Pd value according to partial correlation coefficient analysis (correlation coefficient: -0.232, p=0.027). In the patient group, the correlation between computed thorax tomography score and QTc value was similarly determined according to partial correlation coefficient analysis (Correlation coefficient:0.224, p=0.017). CONCLUSIONS: COVID-19 prolongs QTc and P wave dispersion values; and as the severity of pneumonia increases, QTc value increases. However, whereas the severity of pneumonia increases, P wave dispersion value decreases.

29 April 2026 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
FÖFatih Öztürk
Fatih Öztürk
MYMehmet Yaman
Mehmet Yaman
This study aimed to examine whether the use of sodium–glucose co-transporter 2 inhibitors (SGLT2i) and/or sacubitril/valsartan in individuals with an

19 February 2021 in Angiology
Verified
Journal Article
Open access
PDF file
FOFatih Ozturk
Fatih Ozturk
AAAdem Atici
Adem Atici
HBhasan ali barman
hasan ali barman

14 August 2021
Verified
Book
Closed access
PDF file
HGHüseyin Güdücüoğlu
Hüseyin Güdücüoğlu
MSMahmut Sünnetçioğlu
Mahmut Sünnetçioğlu
ASAbdullah Sarıöz
Abdullah Sarıöz
IBİrFan Binici
İrFan Binici
AMAyfer Meral
Ayfer Meral
SDSinemis Çetin Dağlı
Sinemis Çetin Dağlı
İnsanoğlu tarihi boyunca birçok trajedi, afet ve kaos yaşamıştır. Bu kötü süreçlerin mağdurları, ölenleri, afetzedeleri, kazazedeleri, haksızlığa uğrayanları mutlaka olmuştur. Lakin insanlık tarihinin hiçbir kaosunun insanları sevdiklerini, çocuklarını, ailelerini kucaklamaktan alıkoyabileceğini; karşılarında olmasına rağmen gözyaşlarıyla uzaktan uzağa hasret gidermelerine mahkum edeceğini tahayyül edemezdik. Bu kitaptaki akademik ve deneyimsel alın terini COVID-19 Pandemisinde iyileştirmek istedikleri insanlardan sevdiklerine taşıdıkları hastalık nedeniyle yakınlarını kaybeden; çocuklarına ve sevdiklerine aylarca sarılmaktan kendini hüzünle men etmek zorunda kalan koca yürekli sağlık çalışanlarına atfederim.

20 June 2022
Verified
Book
Closed access
PDF file
ETEmine Zeynep Tarini
Emine Zeynep Tarini
ÇÜÇağın Mustafa Üreyen
Çağın Mustafa Üreyen
NBNaci Babat
Naci Babat
DADursun Akaslan
Dursun Akaslan
SMSelda MURAT
Selda MURAT
BEBerat Engin
Berat Engin